Update on PET glucose neuroimaging
Authors: Buchsbaum M. S.; Hazlett E. A.
Source: International Review of Psychiatry, Volume 9, Number 4, 1 December 1997 , pp. 339-354(16)
Publisher: Informa Healthcare
Abstract:
Summary Positron emission tomography with 18F-deoxyglucose yields high-resolution images of brain activity with accurate quantification of a fundamental property of central nervous system function, cerebral glucose metabolic rate. Alone among brain-imaging modalities, the deoxyglucose method can be applied with microscopic resolution in animal studies, permitting detailed comparison of pharmacological response in both human and non-human experiments. In schizophrenia, metabolic imaging has identified functional changes in components of the fronto-striato-thalamic circuits and the temporal lobe, and visualized changes with neuroleptic, anxiolytic and antidepressant treatment.Language: English
Document Type: Research article
Publication date: 1997-12-01
- Information for Authors
- Subscribe to this Title
- Terms & Conditions
- ingentaconnect is not responsible for the content or availability of external websites
- In this: publication
- By this: publisher
- In this Subject: Neurology & Psychiatry
- By this author: Buchsbaum M. S. ; Hazlett E. A.

Shopping cart
Receive new issue alert